These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3859929)

  • 1. High-dose cytosine arabinoside in the treatment of resistant acute leukemia.
    Takaku F; Urabe A; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):144-9. PubMed ID: 3859929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
    Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
    Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of clinical studies with high-dose cytosine arabinoside at the M.D. Anderson Hospital.
    Keating MJ; Estey E; Plunkett W; Iacoboni S; Walters R; Kantarjian H; Andersson B; Beran M; McCredie KB; Freireich EJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):98-104. PubMed ID: 3859935
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytosine-arabinoside in the treatment of acute leukemias].
    Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
    Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
    [No Abstract]   [Full Text] [Related]  

  • 5. Central nervous system toxicity with high-dose cytosine arabinoside.
    Herzig RH; Lazarus HM; Herzig GP; Coccia PF; Wolff SN
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):233-6. PubMed ID: 3892703
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose cytosine arabinoside in acute leukemia: a cooperative study].
    Urabe A; Takaku F; Mizoguchi H; Yamada O; Wakabayashi Y; Miura Y; Sakamoto S; Yoshida M; Miwa S; Asano S
    Rinsho Ketsueki; 1985 Feb; 26(2):184-8. PubMed ID: 3894715
    [No Abstract]   [Full Text] [Related]  

  • 8. Experience with the use of cytosine arabinoside in adult acute leukaemia.
    Brodie GN; Penny R
    Med J Aust; 1970 Mar; 1(13):635-7. PubMed ID: 5267173
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of central nervous system leukemia with intrathecal cytosine arabinoside.
    Band PR; Holland JF; Bernard J; Weil M; Walker M; Rall D
    Cancer; 1973 Oct; 32(4):744-8. PubMed ID: 4201653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of refractory acute leukemia with high-dose cytosine arabinoside.
    Liu MC; Chen YC; Tsay W; Shen MC; Wang CH; Liu CH
    Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):628-33. PubMed ID: 3655707
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.
    Altundag O; Altundag K; Celik I; Turker A; Kars A
    Am J Hematol; 2004 Apr; 75(4):263-4. PubMed ID: 15054828
    [No Abstract]   [Full Text] [Related]  

  • 15. Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.
    Jones GR; Ettinger LJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):150-4. PubMed ID: 3874431
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
    Herzig RH; Coccia PF; Lazarus HM; Strandjord SE; Graham-Pole J; Cheung NK; Gordon EM; Gross S; Spitzer TR; Warkentin PI
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):184-6. PubMed ID: 3892700
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytosine arabinoside in the treatment of acute myeloblastic leukaemia.
    Bailey CC; Geary CG; Israëls MC; Whittaker JA; Brown MJ; Weatherall DJ
    Lancet; 1971 Jun; 1(7712):1268-71. PubMed ID: 4104719
    [No Abstract]   [Full Text] [Related]  

  • 18. [High doses of cytosine arabinoside in the treatment of refractory leukemia].
    Klener P; Háber J; Kolesková E
    Sb Lek; 1987 Sep; 89(8-9):271-5. PubMed ID: 3478794
    [No Abstract]   [Full Text] [Related]  

  • 19. [High-dose cytosine arabinoside administration in the treatment of refractory leukemia].
    Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Suda K
    Rinsho Ketsueki; 1985 Aug; 26(8):1258-64. PubMed ID: 3865002
    [No Abstract]   [Full Text] [Related]  

  • 20. Preliminary evaluation of cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in acute leukemia of children.
    Freedman MH; Finklestein JZ; Gilchrist GS; Hammond GD; Higgins GR; Hyman CB; Shore NA; Williams KO; Karon MR
    Cancer Chemother Rep; 1969 Oct; 53(5):299-303. PubMed ID: 5270583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.